The usamricd requires a call order from DSI for finepointe software system upgrades, inhalation towers and ponemah expansion to support research projects.
Ended Awarded Last action
- Contract number
- HT942523F0315
- Awardee
-
Harvard Bioscience Inc. UEI MUGFN52A5NJ1 Part of Harvard Bioscience Inc.
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $222,125
Award facts
- Contract value 100% obligated
- $222,124.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 339113 Surgical Appliance and Supplies Manufacturing
- Set-aside
- No set-aside
- Competition
- 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Mounds View, MN 55112, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) awarded a firm fixed-price call order valued at $222,124.57 to Harvard Bioscience Inc., operating through its Data Sciences International division, on September 5, 2023. This contract call order was issued under a single-award Blanket Purchase Agreement with the Defense Health Agency valued at $4.8 million and effective through May 3, 2027. The award required no set-aside designation and will be performed at the contractor's facility in Mounds View, Minnesota. The call order supports USAMRIID research projects through procurement of Finepointe software system upgrades, inhalation towers, and Ponemah expansion capabilities—specialized biomedical research equipment and data acquisition systems essential to the agency's preclinical research mission.
Harvard Bioscience Inc. is a self-certified small disadvantaged business headquartered in New Brighton, Minnesota, specializing in advanced physiological monitoring technologies, wireless implantable telemetry systems, and data acquisition software platforms used across federal biomedical research initiatives. The company has established itself as a critical supplier to the Defense Health Agency, Army Medical Command, National Institutes of Health, and other federal agencies, with cumulative task order activity under the Defense Health Agency BPA exceeding $1.5 million. This contract award reflects the contractor's demonstrated expertise in delivering sophisticated scientific instrumentation and software solutions that enable complex medical research across the defense and military healthcare sectors.
Quick answers
Who was awarded contract HT942523F0315?
HT942523F0315 was awarded to Harvard Bioscience Inc. by Defense Health Agency (Department of Defense) on September 5, 2023.
How much is contract HT942523F0315 worth?
The government has obligated $222,125 on HT942523F0315.
Is contract HT942523F0315 an order under another contract?
Yes. HT942523F0315 is a BPA call under W81XWH22A0001, a blanket purchase agreement.
Was contract HT942523F0315 competed?
The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award